Targeting tumor vascularization: promising strategies for vascular normalization
- 19 June 2021
- journal article
- review article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 147 (9) , 2489-2505
Abstract
Tumor recurrence after the clinical cure of tumor often results from the presence of an abnormal microenvironment, including an aberrant vasculature. The tumor microenvironment is rich in pro-angiogenic factors but lacks pro-maturation factors. Pro-angiogenic conditions in the tumor microenvironment, such as hypoxia, are double-edged swords, promoting both the repair of normal tissues and the development of an abnormal blood vessel network. The coexistence of perfusion and hypoxic zones and uneven blood vessel distribution in tumor tissues profoundly influence tumor deterioration, recurrence, and metastasis. Traditional anti-angiogenic therapies have shown limited efficacy, and promote drug resistance, and even metastasis. In contrast, vascular normalization therapy induces a more physiological-like state, leading to better outcomes and fewer side effects. Vascular normalization entails modifying the tumor vascular system to improve tumor oxygenation and substance transport, thereby contributing to improving the efficacy of radiotherapy, chemotherapy, and immunotherapy. This review mainly focuses on the process of tumor vascularization; potential therapeutic targets, including cells, metabolism, signaling pathways, and angiogenesis-related genes; and possible strategies to normalize blood vessels through regulating tumor vessel generation, the development of tumor vessels, and blood vessel fusion and pruning.Keywords
Funding Information
- National Natural Science Foundation of China (81772694)
This publication has 128 references indexed in Scilit:
- Reactive oxygen species-responsive miR-210 regulates proliferation and migration of adipose-derived stem cells via PTPN2Cell Death & Disease, 2013
- Endothelial Wnt/β-catenin signaling inhibits glioma angiogenesis and normalizes tumor blood vessels by inducing PDGF-B expressionJournal of Experimental Medicine, 2012
- Therapeutic angiogenesis due to balanced single‐vector delivery of VEGF and PDGF‐BBThe FASEB Journal, 2012
- Molecular control of endothelial cell behaviour during blood vessel morphogenesisNature Reviews Molecular Cell Biology, 2011
- HIF Induces Human Embryonic Stem Cell Markers in Cancer CellsCancer Research, 2011
- Scaling rules for diffusive drug delivery in tumor and normal tissuesProceedings of the National Academy of Sciences, 2011
- MicroRNA-132–mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesisNature Medicine, 2010
- A role for VEGF as a negative regulator of pericyte function and vessel maturationNature, 2008
- Modes of resistance to anti-angiogenic therapyNature Reviews Cancer, 2008
- Molecular regulation of vessel maturationNature Medicine, 2003